Our work spans the spectrum of activity required to deliver innovative medical devices to market. PlazaBridge Group has worked with both F100 companies in launching new devices and helped smaller companies shepherd grant-developed prototypes through FDA certification processes.
For one of our smaller clients, our teams developed a validation and certification strategy for a company receiving an SBIR to develop an innovative immunoassay reader leveraging SARs and Spectroscopy science. We saught and obtained participation in the NIH Commercial Assistance Program (CAP). The PlazaBridge Group team attended the conferences and created the necessary documentation supporting the NIH program. Final presentations and reports were delivered in Washington, D.C. to NIH senior managers. Business development activities with key CAP advisors from leading medical device companies followed from our efforts. Our team also assisted the company in developing 510K support materials and consulted on the execution.
We assisted a large medical device company who wanted to rebrand a lesser-known device to bring revenues in line with senior management expectations. The division head sought our expertise in exposing his device’s value to a larger on-line audience. The development of new strategic value messages preceded a content development effort. The new content leveraged greater insight into consumer on-line behavior and a greater understanding of how the corporate website traffic could lead to larger device page traffic. The net results were greater brand awareness as measured by traffic analytics, content pick-up and content downloads.